| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |